Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $36.8 million.

  • Orchestra BioMed Holdings' Shares Outstanding (Diluted Average) rose 38.71% to $52.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.2 million, marking a year-over-year increase of 38.71%. This contributed to the annual value of $36.8 million for FY2024, which is 10.82% up from last year.
  • Orchestra BioMed Holdings' Shares Outstanding (Diluted Average) amounted to $36.8 million in FY2024, which was up 10.82% from $33.2 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Shares Outstanding (Diluted Average) registered a high of $36.8 million during FY2024, and its lowest value of $15.0 million during FY2022.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $28.3 million, with a median of $33.2 million in 2023.
  • Data for Orchestra BioMed Holdings' Shares Outstanding (Diluted Average) shows a peak YoY surged of 121.67% (in 2023) over the last 5 years.
  • Orchestra BioMed Holdings' Shares Outstanding (Diluted Average) (Yearly) stood at $15.0 million in 2022, then soared by 121.67% to $33.2 million in 2023, then grew by 10.82% to $36.8 million in 2024.